Market Place
Sourcing Support
All News #Library
Others
Silexion Therapeutics Reports 2025 Financial Results
17 Mar 2026 //
GLOBENEWSWIRE
Silexion Therapeutics Regains Compliance with Nasdaq LR
25 Sep 2025 //
GLOBENEWSWIRE
Silexion Reports Preclinical Win for SIL204 in Lung Cancer
09 Jul 2025 //
GLOBENEWSWIRE
Silexion Therapeutics Completes Expanded Development Plan for SIL
21 Mar 2025 //
GLOBENEWSWIRE
Silexion Therapeutics Reports 2024 Financial Results & Update
18 Mar 2025 //
GLOBENEWSWIRE
Silexion Nears Key Preclinical Data in PESG Industry Update
03 Mar 2025 //
BUSINESSWIRE
Silexion`s Systemic Delivery Breakthrough Boosts Precision Oncology
29 Jan 2025 //
BUSINESSWIRE
Silexion Announces Exercise of Warrants for 3.3 M Gross Proceeds
29 Jan 2025 //
GLOBENEWSWIRE
Silexion SIL-204 Reduces Tumor Growth In Pancreatic Cancer Model
28 Jan 2025 //
GLOBENEWSWIRE
Silexion To Present SIL-204 Data In KRAS Pancreatic Cancer At ASCO
13 Jan 2025 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.